Proshares Ultra Health Etf Price To Earning
| RXL Etf | USD 48.44 0.79 1.66% |
ProShares Ultra Health fundamentals help investors to digest information that contributes to ProShares Ultra's financial success or failures. It also enables traders to predict the movement of ProShares Etf. The fundamental analysis module provides a way to measure ProShares Ultra's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProShares Ultra etf.
ProShares |
ProShares Ultra Health ETF Price To Earning Analysis
ProShares Ultra's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current ProShares Ultra Price To Earning | 17.93 X |
Most of ProShares Ultra's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProShares Ultra Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
ProShares Ultra Price To Earning Component Assessment
Based on the latest financial disclosure, ProShares Ultra Health has a Price To Earning of 17.93 times. This is 224.82% higher than that of the ProShares family and 5.3% lower than that of the Family category. The price to earning for all United States etfs is notably lower than that of the firm.
ProShares Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ProShares Ultra's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of ProShares Ultra could also be used in its relative valuation, which is a method of valuing ProShares Ultra by comparing valuation metrics of similar companies.ProShares Ultra is currently under evaluation in price to earning as compared to similar ETFs.
Fund Asset Allocation for ProShares Ultra
The fund invests 200.06% of asset under management in tradable equity instruments, with the rest of investments concentrated in .Asset allocation divides ProShares Ultra's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
ProShares Fundamentals
| Price To Earning | 17.93 X | |||
| Price To Book | 2.99 X | |||
| Price To Sales | 2.10 X | |||
| Number Of Employees | 10 | |||
| Beta | 1.33 | |||
| Total Asset | 86.68 M | |||
| One Year Return | 17.30 % | |||
| Three Year Return | (1.60) % | |||
| Five Year Return | 10.90 % | |||
| Ten Year Return | 12.50 % | |||
| Net Asset | 86.68 M | |||
| Last Dividend Paid | 0.15 | |||
| Equity Positions Weight | 200.06 % |
About ProShares Ultra Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProShares Ultra Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares Ultra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares Ultra Health based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ProShares Ultra Piotroski F Score and ProShares Ultra Altman Z Score analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
The market value of ProShares Ultra Health is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Ultra's value that differs from its market value or its book value, called intrinsic value, which is ProShares Ultra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Ultra's market value can be influenced by many factors that don't directly affect ProShares Ultra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Ultra's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Ultra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Ultra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.